Literature DB >> 24451968

Helicobacter pylori infection: an overview in 2013, focus on therapy.

Rongli Cui1, Liya Zhou2.   

Abstract

OBJECTIVE: This article aimed to review the incidence of Helicobacter pylori (H. pylori) infection and its therapy. DATA SOURCES: Relevant articles published in English were identified by searching in PubMed from 2000 to 2013, with keywords "H. pylori". Important references from selected articles were also retrieved from Elsevier, Wiley, EBSCO, and SPRINGER. The Chinese articles published were searched from China National Knowledge Infrastructure (CNKI). STUDY SELECTION: Articles about "prevalence", "gastric carcinoma", "peptic ulcer", "gastroesophageal reflux disease", "functional dyspepsia", "pathogenic mechanism", "therapy", "eradication rate", "antibiotic resistance", and "gene polymorphisms" were selected.
RESULTS: The decreased infection rates of H. pylori could also be linked to the changed disease spectrum, such as the decreased morbidity and recurrence rate of H. pylori-related peptic ulcer, and the increased morbidity of gastroesophageal reflux. Although different treatment regimens have been used for H. pylori infection, the H. pylori eradication rate declined gradually. Due to primary resistance to antibiotics, the gene polymorphism of host and infected strain, and the therapy regimes, H. pylori eradication became even more difficult.
CONCLUSIONS: The prevalence of H. pylori infection had been decreasing, but the rate of eradication failure has dramatically risen in many countries due to resistance to antibiotic. H. pylori therapy in clinical practice is becoming progressively more difficult.

Entities:  

Mesh:

Year:  2014        PMID: 24451968

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

Review 1.  Helicobacter pylori colonization of the oral cavity: A milestone discovery.

Authors:  John K C Yee
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

2.  Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?

Authors:  Halil Rakici; Remzi Adnan Akdogan; Teslime Ayaz; Recep Bedir
Journal:  Gastroenterol Res Pract       Date:  2015-03-15       Impact factor: 2.260

3.  Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial.

Authors:  Aliakbar Hajaghamohammadi; Seyyed Hossein Safiabadi Tali; Rasoul Samimi; Sonia Oveisi; Amir Mohammad Kazemifar
Journal:  Glob J Health Sci       Date:  2014-08-31

Review 4.  Therapy of Helicobacter pylori: present medley and future prospective.

Authors:  Amin Talebi Bezmin Abadi
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

5.  Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS).

Authors:  Zhining Liu; Weidong Ren; Jintao Guo; Ying Zhao; Siyu Sun; Yuhong Li; Zhijun Liu
Journal:  Gastric Cancer       Date:  2018-01-25       Impact factor: 7.370

6.  Helicobacter pylori eradication: influence of interleukin-1beta -31 C/T polymorphism.

Authors:  Tássia Flores Rech; Luiz Edmundo Mazzoleni; Felipe Mazzoleni; Carlos Fernando de Magalhães Francesconi; Guilherme Becker Sander; Rafael Tomoya Michita; Débora Dreher Nabinger; Tobias Cancian Milbradt; Ronaldo João Spinato Torresini; Daniel Simon
Journal:  Braz J Infect Dis       Date:  2018-07-24       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.